Zhong Yuan Bio-Technology Holdings (Zhong Yuan Bio-Technology Holdings) LT-Debt-to-Total-Asset : 0.20 (As of Sep. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Zhong Yuan Bio-Technology Holdings LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Zhong Yuan Bio-Technology Holdings's long-term debt to total assests ratio for the quarter that ended in Sep. 2023 was 0.20.

Zhong Yuan Bio-Technology Holdings's long-term debt to total assets ratio declined from Sep. 2022 (0.24) to Sep. 2023 (0.20). It may suggest that Zhong Yuan Bio-Technology Holdings is progressively becoming less dependent on debt to grow their business.

Zhong Yuan Bio-Technology Holdings LT-Debt-to-Total-Asset Historical Data

The historical data trend for Zhong Yuan Bio-Technology Holdings's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhong Yuan Bio-Technology Holdings LT-Debt-to-Total-Asset Chart

Zhong Yuan Bio-Technology Holdings Annual Data

Trend

Dec16

Dec17

Dec18

Mar19

Mar20

Mar21

Mar22

Mar23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.08

0.35

0.38

0.26

Zhong Yuan Bio-Technology Holdings Semi-Annual Data
	Jun17	Dec17	Jun18	Dec18	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial								0.41	0.38	0.24	0.26	0.20

Zhong Yuan Bio-Technology Holdings LT-Debt-to-Total-Asset Calculation

Zhong Yuan Bio-Technology Holdings's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Mar. 2023 is calculated as

LT Debt to Total Assets (A: Mar. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Mar. 2023 )	/	Total Assets (A: Mar. 2023 )
	=	0.596	/	2.28
	=	0.26

Zhong Yuan Bio-Technology Holdings's Long-Term Debt to Total Asset Ratio for the quarter that ended in Sep. 2023 is calculated as

LT Debt to Total Assets (Q: Sep. 2023 )	=	Long-Term Debt & Capital Lease Obligation (Q: Sep. 2023 )	/	Total Assets (Q: Sep. 2023 )
	=	0.64	/	3.224
	=	0.20

Zhong Yuan Bio-Technology Holdings (OTCPK:ZHYBF) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Zhong Yuan Bio-Technology Holdings LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Zhong Yuan Bio-Technology Holdings's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhong Yuan Bio-Technology Holdings (Zhong Yuan Bio-Technology Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Zhong Yuan Bio-Technology Holdings Ltd (OTCPK:ZHYBF) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

28 Queen’s Road East, Suite 901, Tesbury Centre, Wanchai, Hong Kong, HKG

Website

https://www.zybioholdings.com

Zhong Yuan Bio-Technology Holdings Ltd is engaged in the business of developing and marketing nervonic acid-based health supplements and sales of acer truncatum seedlings. The company has two reportable segments such as sales of health care supplements and technical supporting services. The company generates its revenue primarily from the sales of health care supplements.

Executives

Tingting Chang	director, 10 percent owner, officer: CEO	RM 1002, 10THFL, LONG HU FUTURE OFFICE, NO. 1 EAST SHI LI PU ROAD, CHAO YANG DISTRICT, BEIJING F4 100024
James M Cassidy	director, 10 percent owner, officer: president,secretary,treasurer	215 APOLENA AVENUE, NEWPORT BEACH CA 92662
James K Mckillop	director, 10 percent owner, officer: Vice President	9454 WILSHIRE BOULEVARD, SUITE 612, BEVERLY HILLS CA 90212

Zhong Yuan Bio-Technology Holdings (Zhong Yuan Bio-Technology Holdings) Headlines

No Headlines